Cooper Companies (COO) Net Income towards Common Stockholders (2009 - 2026)
Cooper Companies' (COO) quarterly Net Income towards Common Stockholders came in at -$77.9 million in Q2 2026, down 188.83% year-on-year from $87.7 million in Q2 2025, and down 159.56% quarter-over-quarter from $130.8 million in Q1 2026.
Cooper Companies (COO) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Cooper Companies' Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at -$77.9 million for Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 188.83% year-over-year to -$77.9 million in Q2 2026; TTM through Apr 2026 was $235.8 million, a 43.07% decrease from a year earlier, with the FY2025 full-year figure at $374.9 million, down 4.44% from the prior year.
- Net Income towards Common Stockholders fell to -$77.9 million in Q2 2026 per COO's latest filing, from $130.8 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $130.8 million in Q1 2026 and bottomed at -$77.9 million in Q2 2026.
- The 5-year median for Net Income towards Common Stockholders is $88.3 million (2024), against an average of $83.3 million.
- Across the five-year window, Net Income towards Common Stockholders jumped 123.37% in 2024 and slumped 188.83% in 2026, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at $65.6 million in 2022, then grew by 28.81% to $84.5 million in 2023, then surged by 39.05% to $117.5 million in 2024, then dropped by 28.0% to $84.6 million in 2025, then tumbled by 192.08% to -$77.9 million in 2026.
- Per Business Quant, the three latest COO Net Income towards Common Stockholders figures stand at -$77.9 million (Q2 2026), $130.8 million (Q1 2026), and $84.6 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.97 Bn | 120.75 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.74 Bn | 43.93 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.94 Bn | 31.28 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.85 Bn | 30.61 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.60 Bn | 23.16 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 13.99 Bn | 13.43 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.76 Bn | 13.62 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Baxter International | 11.94 Bn | 9.93 Bn | 891.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -77.90 Mn |
| Jan 31, 2026 | 130.80 Mn |
| Oct 31, 2025 | 84.60 Mn |
| Jul 31, 2025 | 98.30 Mn |
| Apr 30, 2025 | 87.70 Mn |
| Jan 31, 2025 | 104.30 Mn |
| Oct 31, 2024 | 117.50 Mn |
| Jul 31, 2024 | 104.70 Mn |
| Apr 30, 2024 | 88.90 Mn |
| Jan 31, 2024 | 81.20 Mn |
| Oct 31, 2023 | 84.50 Mn |
| Jul 31, 2023 | 85.30 Mn |
| Apr 30, 2023 | 39.80 Mn |
| Jan 31, 2023 | 84.60 Mn |
| Oct 31, 2022 | 65.60 Mn |
| Jul 31, 2022 | 98.40 Mn |
| Apr 30, 2022 | 126.60 Mn |
| Jan 31, 2022 | 95.30 Mn |
| Oct 31, 2021 | 110.30 Mn |
| Jul 31, 2021 | 615.80 Mn |